Solana (HSDT) Stock Price

Solana Price

NYSE·CLOSED
1.64
​
Market closed

Over the last 7 years Solana grew revenue by 43.6% annually, reaching 6.02 M USD. For Solana, the net margin of -679.6% is up versus -3,473.6% a few years ago. The consensus 12-month price target for Solana is 4.08 USD, about 148.8% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Solana stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Solana business model & stock analysis

Helius Medical Technologies develops and markets the PoNS device, a portable neuromodulation stimulator for neurological wellness. The company focuses on non-invasive platform technologies that enhance the brain's healing ability. The PoNS device is authorized as a class II medical device in Canada for short-term treatment of chronic balance deficits caused by mild-to-moderate traumatic brain injury, used alongside physical therapy. It delivers non-invasive neurostimulation to the tongue to induce neuromodulation. Helius Medical Technologies targets healthcare providers and rehabilitation centers that treat patients with traumatic brain injury. The company's product is designed for use in clinical settings under professional guidance, specifically for patients requiring short-term balance deficit therapy. The PoNS device is positioned as a complementary treatment within physical therapy protocols for neurological rehabilitation. The firm's revenue model is based on the sale of the PoNS device to healthcare institutions and rehabilitation facilities. These institutions purchase the device for use in their treatment programs, leveraging its non-invasive neurostimulation technology to address balance deficits in patients with mild-to-moderate traumatic brain injury. The company's focus on neurological wellness through non-invasive solutions drives its commercial strategy.

Frequently asked questions about Solana

Analysts currently set an average price target of 4.08 USD for the Solana stock (median: 4.08 USD), implying +135.8 % versus the latest price. The consensus is based on 7 analyst ratings.

8 analysts currently rate the Solana stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Solana to generate revenue of 12.25 M USD and earnings per share of -0.00 USD.

Converted at the current exchange rate, the Solana share trades at 1.49 EUR (1.64 USD).

The expected revenue of Solana is 12.25 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Solana is -5,904.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Solana is currently -6,124.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Solana stock.

The price-to-sales ratio (P/S) of Solana is currently 2.95. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Solana stock.

The Eulerpool Quality Score for Solana is 6/10.

The ISIN of Solana is US42328V8761. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Solana is A2JB8E. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Solana is HSDT. The ticker symbol is used to trade Solana shares on the stock exchange.

Fair ValueTerminal
1.44 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
286,523.81 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jun 27, 2014
ISIN
US42328V8761
Cusip
42328V603
Sedol
BMXLWX0
Market capitalization
5,904.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-6,124.39
P/Ee 2027
164.00
P/Ee 2028
11.71
P/S
P/Se
2.95
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-13.59 %
Last updated Nov 17, 2026, 3:47 AM

All fundamentals and in-depth analysis of Solana

Our stock analysis for Solana stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Solana. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.